BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9282280)

  • 1. Circulating intercellular adhesion molecule-1 in patients with hepatocellular carcinoma.
    Soresi M; Cervello M; Lipani G; Carroccio A; Cartabellotta A; Marasà L; Casto C; Virruso L; Montalto G
    Eur J Gastroenterol Hepatol; 1997 Aug; 9(8):805-9. PubMed ID: 9282280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of adhesion molecule expression and soluble fractions in hepatic resection.
    Shimada M; Kajiyama K; Hasegawa H; Gion T; Ikeda Y; Shirabe K; Takenaka K; Sugimachi K
    J Am Coll Surg; 1998 May; 186(5):534-41. PubMed ID: 9583693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of hepatitis C virus infection on circulating levels of sICAM-1 and VEGF in patients with hepatitis C and hepatocellular carcinoma (HCC) and their role in enhancing detection of HCC.
    Helaly GF; Abou Shamaa LA
    Egypt J Immunol; 2006; 13(1):27-38. PubMed ID: 17974148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasion and metastasis of liver cancer: expression of intercellular adhesion molecule 1.
    Sun JJ; Zhou XD; Liu YK; Tang ZY; Feng JX; Zhou G; Xue Q; Chen J
    J Cancer Res Clin Oncol; 1999; 125(1):28-34. PubMed ID: 10037274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased intercellular adhesion molecule-1 serum concentration in cholestasis.
    Polzien F; Ramadori G
    J Hepatol; 1996 Dec; 25(6):877-86. PubMed ID: 9007716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum concentration of intercellular adhesion molecule-1 in patients with hepatocellular carcinoma is a marker of the disease progression and prognosis.
    Shimizu Y; Minemura M; Tsukishiro T; Kashii Y; Miyamoto M; Nishimori H; Higuchi K; Watanabe A
    Hepatology; 1995 Aug; 22(2):525-31. PubMed ID: 7543436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating intercellular adhesion molecule-1 in chronic liver disease and hepatocellular carcinoma.
    Huang YS; Wu JC; Chan CY; Chao Y; Chang FY; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Aug; 62(8):487-95. PubMed ID: 10462824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of human intercellular adhesion molecule 1 in the blood is useful for predicting the occurrence of hepatocellular carcinomas from chronic hepatitis C and liver cirrhosis.
    Moriyama M; Matsumura H; Shioda J; Aoki H; Nakamura H; Arakawa Y; Nirei K; Yamagami H; Kaneko M; Tanaka N; Arakawa Y
    Intervirology; 2006; 49(6):327-38. PubMed ID: 16926545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating intercellular adhesion molecule-1 in chronic hepatitis C patients with normal or elevated aminotransferase before and after alpha-interferon treatment.
    Montalto G; Giannitrapani L; Soresi M; Florena A; Di Martino D; Franco V; Carroccio A; Cervello M
    Intervirology; 2003; 46(1):35-42. PubMed ID: 12566697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of circulating intercellular adhesion molecule-1 in hepatocellular carcinoma.
    Hyodo I; Jinno K; Tanimizu M; Hosokawa Y; Nishikawa Y; Akiyama M; Mandai K; Moriwaki S
    Int J Cancer; 1993 Nov; 55(5):775-9. PubMed ID: 7503959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of serum sICAM-1 in patients with primary hepatocellular carcinoma and its relationship with liver fibrosis].
    Zhou SL; Chen YL; Peng XZ; Zhao YX; Xie PZ; Ling L; Chen XW; Dai KM
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Feb; 28(2):181-2. PubMed ID: 23162921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
    Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
    World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of a soluble form of the human adhesion receptor lymphocyte function-associated antigen-3 (LFA-3) in patients with chronic liver disease.
    Hoffmann JC; Bahr MJ; Tietge UJ; Braunstein J; Bayer B; Böker KH; Manns MP
    J Hepatol; 1996 Oct; 25(4):465-73. PubMed ID: 8912145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy.
    Rühl R; Seidensticker M; Peters N; Mohnike K; Bornschein J; Schütte K; Amthauer H; Malfertheiner P; Pech M; Ricke J
    Dig Dis; 2009; 27(2):189-99. PubMed ID: 19546558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiality of α-fetoprotein (AFP) and soluble intercellular adhesion molecule-1 (sICAM-1) in prognosis prediction and immunotherapy response for patients with hepatocellular carcinoma.
    Cao W; Chen Y; Han W; Yuan J; Xie W; Liu K; Qiu Y; Wang X; Li X
    Bioengineered; 2021 Dec; 12(2):9435-9451. PubMed ID: 34696675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model.
    Zekri AR; Youssef AS; Bakr YM; Gabr RM; Ahmed OS; Elberry MH; Mayla AM; Abouelhoda M; Bahnassy AA
    World J Gastroenterol; 2016 Apr; 22(16):4168-82. PubMed ID: 27122667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis.
    Collazos J
    Cancer; 1992 Sep; 70(5):1202-3. PubMed ID: 1381271
    [No Abstract]   [Full Text] [Related]  

  • 18. Intercellular adhesion molecule-1 release from human hepatocellular carcinoma.
    Hyodo I; Jinno K; Tanimizu M; Doi T; Nishikawa Y; Hosokawa Y; Moriwaki S
    Cancer Detect Prev; 1996; 20(4):308-15. PubMed ID: 8818391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of correlation between interferon-γ and soluble intercellular adhesion molecule-1 and interleukin-17 in hepatitis B virus-related cirrhosis.
    Chen H; Zhang D; Wang S; Wang X; Yang C
    Clin Res Hepatol Gastroenterol; 2013 Dec; 37(6):608-13. PubMed ID: 23796976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the albumin-gamma-glutamyltransferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis.
    Pompili M; Addolorato G; Pignataro G; Rossi C; Zuppi C; Covino M; Grieco A; Gasbarrini G; Rapaccini GL
    J Gastroenterol Hepatol; 2003 Mar; 18(3):288-95. PubMed ID: 12603529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.